NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH HIV-1 ACTG 1025

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。ACTG 219c这项研究的目的是收集和研究有关您和您的医疗保健的临床和实验室信息，以增加我们对感染艾滋病毒的孕妇及其子女的最佳护理的了解。这项研究将着眼于不同的药物在降低艾滋病毒感染母亲所生婴儿感染艾滋病毒的几率方面的效果。这项研究还将研究不同的药物如何降低血液中的病毒数量或增加血细胞，帮助身体对抗感染。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219c The purpose of this study is to collect and study clinical and laboratory information about you and your medical care in order to increase our knowledge of the best care for HIV-infected pregnant women and their children. The study will look at how good different medications are in lowering the chance that a baby born to an HIV-infected mother will get HIV.The study will also look at how different medicines work to lower the amount of virus in the blood or increase the blood cells that help the body fight infection.